Clinical Trials Directory

Trials / Unknown

UnknownNCT01299753

Catecholamine Blockade Post-burn

Clinical and Molecular Effects of Catecholamine Blockade Post-burn

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Severe burn is associated with a wide array of stress, metabolic, and physiologic processes in an attempt to restore homeostasis. The catecholamine induced stress response following severe burns is particularly exaggerated and manifests detrimentally as inflammation, insulin resistance, hypermetabolism, and associated profound protein catabolism. The investigators hypothesize that catecholamine blockade will lead to restored IR signaling and result in improved post-burn morbidity. The investigators will further determine the molecular mechanisms mediating these effects.

Conditions

Interventions

TypeNameDescription
DRUGplaceboidentically packed placebo
DRUGpropranolol20-40 mg q6-8h

Timeline

Start date
2011-02-01
Primary completion
2022-12-31
Completion
2023-12-31
First posted
2011-02-18
Last updated
2022-03-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01299753. Inclusion in this directory is not an endorsement.